The Export of Immunoglobulin D by Human Neoplastic B Lymphocytes

Overview

Journal J Exp Med

Specialties Allergy & Immunology
General Medicine

Date 1983 Jan 1

PMID 6401318

Citations 1

Authors

F K Stevenson

G T Stevenson

A L Tutt

Affiliations

Soon will be listed here.

Abstract

An investigation has been made into the ability of human neoplastic B lymphocytes expressing surface IgM and IgD to export IgD in culture. Cells that expressed surface Ig of the lambda light chain type frequently exported IgD (10/12 patients), whereas cells expressing surface Ig of the kappa light chain type exported no IgD, although most (8/11 patients) were able to export IgM. It appears, therefore, that in most of the 23 cases studied, cells synthesizing IgD with lambda light chains can both express and export IgD, whereas those synthesizing IgD kappa can only insert it into the surface membrane. This finding and the known preponderance of lambda in plasma IgD imply that the possession of a lambda chain facilitates the IgD secretory pathway, a conclusion that implicates a control mechanism subsequent to the surface/secretory dichotomy arising from different splicings of heavy chain messenger RNA.

Citing Articles

Treatment of lymphoid tumors with anti-idiotype antibodies.

Stevenson G, Stevenson F Springer Semin Immunopathol. 1983; 6(1):99-115.

PMID: 6351310 DOI: 10.1007/BF01857369.

References

Pernis B, Governa M, Rowe D . Light chain types in plasma cells that produce IgD. Immunology. 1969; 16(5):685-9. PMC: 1409596. View

Rowe D, Hug K, Forni L, Pernis B . Immunoglobulin D as a lymphocyte receptor. J Exp Med. 1973; 138(4):965-72. PMC: 2180569. DOI: 10.1084/jem.138.4.965. View

Fu S, Winchester R, KUNKEL H . Similar idiotypic specificity for the membrane IgD and IgM of human B lymphocytes. J Immunol. 1975; 114(1 Pt 1):250-2. View

Ferrarini M, Viale G, Risso A, Pernis B . A study of immunoglobulin classes present on the membrane and in the cytoplasm of human tonsil plasma cells. Eur J Immunol. 1976; 6(8):562-5. DOI: 10.1002/eji.1830060807. View

Spiegelberg H . The structure and biology of human IgD. Immunol Rev. 1977; 37:3-24. DOI: 10.1111/j.1600-065x.1977.tb00243.x. View

Gordon J, Smith J, Newell D, Chisholm M, Corte G, Warley A . Biosynthesis and characterization of intracellular IgDkappa in a case of CLL. Clin Exp Immunol. 1977; 30(1):70-6. PMC: 1541168. View

Corte G, Viale G, Cosulich E, Bargellesi A, Ferrarini M . Characterization of IgD. II. Molecular forms of IgD in human B cells. Scand J Immunol. 1979; 10(3):275-80. DOI: 10.1111/j.1365-3083.1979.tb01350.x. View

Aisenberg A, Wilkes B, Long J, Harris N . Cell surface phenotype in lymphoproliferative disease. Am J Med. 1980; 68(2):206-13. DOI: 10.1016/0002-9343(80)90355-1. View

Singer P, Singer H, Williamson A . Different species of messenger RNA encode receptor and secretory IgM mu chains differing at their carboxy termini. Nature. 1980; 285(5763):294-300. DOI: 10.1038/285294a0. View

10.

Stevenson F, Morris D, Stevenson G . Immunoglobulin produced by guinea-pig leukaemic B lymphocytes: its source and use as a monitor of tumour load. Immunology. 1980; 41(2):313-21. PMC: 1458168. View

11.

Stevenson F, Hamblin T, Stevenson G, Tutt A . Extracellular idiotypic immunoglobulin arising from human leukemic B lymphocytes. J Exp Med. 1980; 152(6):1484-96. PMC: 2186015. DOI: 10.1084/jem.152.6.1484. View

12.

Moore K, Rogers J, Hunkapiller T, Early P, Nottenburg C, Weissman I . Expression of IgD may use both DNA rearrangement and RNA splicing mechanisms. Proc Natl Acad Sci U S A. 1981; 78(3):1800-4. PMC: 319222. DOI: 10.1073/pnas.78.3.1800. View

13.

McCune J, Fu S, KUNKEL H, Blobel G . Biogenesis of membrane-bound and secreted immunoglobulins: two primary translation products of the human delta chain, differentially N-glycosylated to four discrete forms in vivo and in vitro. Proc Natl Acad Sci U S A. 1981; 78(8):5127-31. PMC: 320346. DOI: 10.1073/pnas.78.8.5127. View

14.

Stevenson F, Hamblin T, Stevenson G . The nature of the immunoglobulin G on the surface of B lymphocytes in chronic lymphocytic leukemia. J Exp Med. 1981; 154(6):1965-9. PMC: 2186541. DOI: 10.1084/jem.154.6.1965. View